Please assess the completion status of the following clinical trial:

Trial Title: Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Main Inclusion Criteria:~* Narcoleptic with cataplexy : at least 3 weekly cataplexy attacks~* ESS \> or = 12~* ICF signed and dated~Main Exclusion Criteria:~* Other conditions that could generate EDS~* Psychological and neurological disorders~* Acute or chronic severe disease~* Treatment by prohibited medication

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Pitolisant (Type: EXPERIMENTAL): Pitolisant at 5, 10, 20 or 40mg
- Placebo (Type: PLACEBO_COMPARATOR): Capsules of placebo containing lactose

Based on this trial design, predict the completion outcome and termination type (if applicable).